Article info

Download PDFPDF
Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study

Authors

  • Volkan Tahmaz Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Uta Gehlsen Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Laura Sauerbier Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Udo Holtick Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Lisa Engel Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Stela Radojska Institute of Transfusion Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Viorica-Maria Petrescu-Jipa Institute of Transfusion Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Christof Scheid Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Michael Hallek Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Birgit Gathof Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Institute of Transfusion Medicine, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Claus Cursiefen Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Philipp Steven Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany Competence Center for Ocular GvHD, Medical Faculty, University of Cologne, Cologne, Germany Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Philipp Steven, Department of Ophthalmology, Competence Center for Ocular GvHD, University of Cologne, Kerpener Str. 62, Cologne 50937, Germany; philipp.steven{at}uk-koeln.de
View Full Text

Citation

Tahmaz V, Gehlsen U, Sauerbier L, et al
Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study

Publication history

  • Received October 24, 2015
  • Revised April 12, 2016
  • Accepted May 12, 2016
  • First published June 6, 2016.
Online issue publication 
February 22, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.